<DOC>
	<DOCNO>NCT00868855</DOCNO>
	<brief_summary>Coronary artery disease lead cause death USA . Contemporary cardiac care substantially reduce mortality morbidity patient severe coronary artery disease . However , patient mild moderate coronary artery stenosis ( &lt; 70 % stenosis ) often present future life threaten acute coronary syndrome carry significant mortality morbidity . It difficult predict outcome patient event lack complete understanding mechanism underlie acute coronary syndrome lack reliable marker predict major adverse cardiac event ( MACE ) . Tissue-type plasminogen activator ( t-PA ) release endothelial cell major factor prevent thrombosis coronary artery , cause acute coronary syndrome . Endothelial dysfunction impair t-PA release . Therefore , hypothesize patient impaired coronary artery t-PA release significantly high risk future MACE due intrinsic fibrinolytic dysfunction lead increase thrombosis risk . To test hypothesis , determine whether intrinsic endothelial fibrinolytic dysfunction predicts MACE patient non-significant CAD . The study measure t-PA release mediate bradykinin , major mediator t-PA release . This involve infusion bradykinin leave main coronary artery individual undergone routine cardiac catheterization ( clinically indicate ) . We take blood sample coronary sinus measure t-PA plasminogen activator inhibitor-1 antigen activity level .</brief_summary>
	<brief_title>Tissue-Type Plasminogen Activator ( t-PA ) Release Predicts Major Adverse Cardiac Events ( MACE ) Patients With Non-critical Coronary Artery Disease</brief_title>
	<detailed_description>Tissue-type Plasminogen Activator ( tPA ) protein blood break clot play important role prevent myocardial infarction . It produce endothelial cell line blood vessel . Previous study demonstrate t-PA release response hormone bradykinin acetylcholine . Impaired t-PA release upon bradykinin stimulation may indicate endothelial dysfunction lead development acute coronary syndrome . In project , determine whether impaired t-PA release predict future occurrence acute coronary syndrome . The study involve individual get routine leave heart cardiac catheterization ( indication cardiac catheterization solely base clinical indication ) . Prior procedure , patient two blood sample ( 5 ml ) collect forearm 2 minute blood pressure cuff inflation arm . After routine diagnostic cardiac catheterization severe coronary artery stenosis ( &lt; 70 % stenosis ) , research protocol initiate . Study include infusion increase dos bradykinin leave main coronary artery , sample small amount blood coronary sinus ( 15 ml total ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<mesh_term>Kininogens</mesh_term>
	<criteria>1 . Age &gt; 18 year old male female patient 2 . All patient refer elective cardiac catheterization base clinical indication 3 . Cath show mild moderate ( &lt; 70 % stenosis ) CAD require mechanical intervention 1 . Severe stenosis require intervention . 2 . Significant leave main coronary artery disease ( &gt; 40 % ) . 3 . Acute MI acute coronary syndrome enzyme elevation ischemic EKG change 4 . Patients severe leave ventricular dysfunction ( EF &lt; 35 % ) 5 . Prior history myocardial infarction 6 . History stroke within 3 month . 7 . Recent history thrombolytic 8 . History coronary intervention within previous 6 month . 9 . Patients history coronary spasm 10 . Patients congestive heart failure ( class III IV ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Coronary Artery Disease</keyword>
</DOC>